SilicosisOmics: an integrated multi-omics platform for silicosis

doi:10.16352/j.issn.1001-6325.2026.02.0155

Abstract

Abstract: Objective To address the challenges of fragmented multi-omics data and insufficient integrated analysis in silicosis research, we aim to construct a comprehensive data platform that supports systematic analysis of multi-level molecular alterations in fibrotic lung tissues and facilitates rapid identification of therapeutic targets. Methods We systematically integrated transcriptomic, single-cell transcriptomic, quantitative proteomic, post-translational modification-specific proteomic, and metabolomic data from human and mouse silicotic and control lung tissues. By leveraging bioinformatics tools including DESeq2, Seurat, and CellChat, we developed a web-based visualization platform enabling data visualization and interactive analysis. Results We successfully constructed SilicosisOmics (https://respir.pumc.edu.cn/SilicosisOmics/), a comprehensive multi-omics data platform for silicosis research. The platform integrated five types of omics data derived from both silicotic and non-diseased lung tissues across human and mouse species. SilicosisOmics provided not only online search functionality for static visualization of gene expression and single-cell clustering but also interactive analytical tools supporting user-customized analyses including differential gene expression, pathway enrichment, and cell-cell interaction studies. Conclusions The SilicosisOmics platform offers systematic multi-omics data resources and user-friendly analytical tools for silicosis and pulmonary fibrosis research, thereby facilitating the advancement of mechanistic studies, target discovery, and subsequent translational research.

Key words: silicosis, pulmonary fibrosis, multi-omics, data platform, data sharing

CLC Number:

Q811.4

WANG Jixin, HUANG Xinlei, QI Xianmei, ZHANG Tiantian, PANG Junling, LONG Erping, WANG Jing. SilicosisOmics: an integrated multi-omics platform for silicosis[J]. Basic & Clinical Medicine, 2026, 46(2): 155-163.

References

[1]Leung CC, Yu IT, Chen W. Silicosis[J]. Lancet, 2012, 379: 2008-2018.
[2]Zhang X, Zhao L, He M, et al. Burden of silicosis based on the Global Burden of Disease Study 2021: trend analysis of incidence, mortality, and disability-adjusted life years, and projections for the next 30 years[J]. J Thorac Dis, 2025, 17: 872-886.
[3]Ma J, Li G, Wang H, et al. Comprehensive review of potential drugs with anti-pulmonary fibrosis properties[J]. Biomed Pharmacother, 2024, 173: 116282.doi: 10.1016/j.biopha.2024.116282.
[4]Karczewski KJ, Snyder MP. Integrative omics for health and disease[J]. Nat Rev Genet, 2018, 19: 299-310.
[5]凌鋆超, 曹瑞芳, 李亦学, 等. 多组学大数据共享平台研究进展[J]. 生命科学, 2023, 35: 1553-1560.
[6]Hayes C N, Nakahara H, Ono A, et al. From omics to multi-omics: a review of advantages and tradeoffs[J] 2024, 15:1551. doi: 10.3390/genes15121551.
[7]Arakaki AK, Skolnick J, McDonald JF. Marker metabo-lites can be therapeutic targets as well[J]. Nature, 2008, 456: 443. doi: 10.1038/456443c
[8]Lao Y, Jin Y, Wu S, et al. Deciphering a profiling based on multiple post-translational modifications functionally associated regulatory patterns and therapeutic opportunities in human hepatocellular carcinoma[J]. Mol Cancer, 2024, 23: 283. doi: 10.1186/s12943-024-02199-1.
[9]Lim J, Park C, Kim M, et al. Advances in single-cell omics and multiomics for high-resolution molecular profiling[J]. Exp Mol Med, 2024, 56: 515-526.
[10]Pang J, Qi X, Luo Y, et al. Multi-omics study of silicosis reveals the potential therapeutic targets PGD(2) and TXA(2)[J]. Theranostics, 2021, 11: 2381-2394.
[11]Song M, Wang J, Sun Y, et al. Inhibition of gasdermin D-dependent pyroptosis attenuates the progression of silica-induced pulmonary inflammation and fibrosis[J]. Acta Pharm Sin B, 2022, 12: 1213-1224.
[12]Wolock SL, Lopez R, Klein AM. Scrublet: computational identification of cell doublets in single-cell transcriptomic data[J]. Cell Syst, 2019, 8: 281-91.e9.
[13]Jin S, Guerrero-Juarez CF, Zhang L, et al. Inference and analysis of cell-cell communication using CellChat[J]. Nature Commun, 2021, 12: 1088. doi: 10.1038/s41467-021-21246-9.
[14]Zhang T, Wang Y, Sun Y, et al. Proteome, lysine acetylome, and succinylome identify posttranslational modification of STAT1 as a novel drug target in silicosis[J]. Mol Cell Proteomics, 2024, 23: 100770. doi: 10.1016/j.mcpro.2024.100770.
[15]Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease[J]. Genome Biol, 2017, 18: 83.doi: 10.1186/s13059-017-1215-1.